ClassID:

95151

C07D321/10 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups  - ; Seven-membered rings condensed with carbocyclic rings or ring systems

Recent Application in this class:
#1
20260079396
2026-03-19

RADIATION-SENSITIVE COMPOSITION, METHOD FOR FORMING PATTERN AND ONIUM SALT COMPOUND

#2
20230418158
2023-12-28

Novel Sulfonium Salt, Resist Composition, And Patterning Process

#3
20230266666
2023-08-24

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#4
20230152691
2023-05-18

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#5
20230028443
2023-01-26

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#6
20230004084
2023-01-05

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#7
20220413383
2022-12-29

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#8
20220281805
2022-09-08

Lobaric acid derivative having PTP-1B inhibitory activity, preparation method therefor and use thereof

#9
20220267494
2022-08-25

MONOMER, RESIN FOR PHOTORESIST, RESIN COMPOSITION FOR PHOTORESIST, AND PATTERN FORMING METHOD

#10
20220011668
2022-01-13

Salt, acid generator, resist composition and method for producing resist pattern

#11
20220011667
2022-01-13

SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN

#12
20210388269
2021-12-16

Compound, liquid crystal composition, cured product, optically anisotropic body, and reflective film

#13
20210347752
2021-11-11

BENZAMIDE DERIVATIVES AS CGAS-STING PATHWAY AGONISTS

#14
20210341836
2021-11-04

Salt, acid generator, resist composition and method for producing resist pattern

#15
20210263416
2021-08-26

Carboxylate, carboxylic acid generator, resist composition and method for producing resist pattern

#16
20210255545
2021-08-19

Salt, acid generator, resist composition and method for producing resist pattern

#17
20210226253
2021-07-22

Electrolytic solution for lithium-ion secondary battery, and lithium-ion secondary battery

#18
20210198230
2021-07-01

Compound, composition, cured product, optically anisotropic body, and reflective film

#19
20210189243
2021-06-24

COMPOUND, MIXTURE, LIQUID CRYSTAL COMPOSITION, CURED PRODUCT, OPTICALLY ANISOTROPIC BODY, AND REFLECTIVE FILM

#20
20210187468
2021-06-24

Modular continuous flow device

#21
20210009551
2021-01-14

COMPOUNDS AND METHODS FOR TREATING FIBROSIS OR CANCER

#22
20200115360
2020-04-16

Enzyme-triggered carbon monoxide releasing molecules

#23
20190119200
2019-04-25

TERTIARY AMIDES AND METHOD OF USE

#24
20190117668
2019-04-25

Compositions and methods for treating disorders of circadian and diurnal rhythms using prokineticin 2 agonists and antagonists

#25
20190092720
2019-03-28

FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION

#26
20180291271
2018-10-11

Chiral compounds

#27
20180065925
2018-03-08

Salt and photoresist composition containing the same

#28
20180065924
2018-03-08

Salt and photoresist composition containing the same

#29
20170365798
2017-12-21

Fluorinated aromatic small molecules as functional additives for dispersion of conductive polymers

#30
20160311792
2016-10-27

Sulfamate derivative compounds for use in treating or alleviating pain

#31
20160168116
2016-06-16

IRE-1α inhibitors

#32
20160154304
2016-06-02

Salt, acid generator, resist composition and method for producing resist pattern

#33
20150338735
2015-11-26

Salt, acid generator, photoresist composition and process of producing photoresist pattern

#34
20150328617
2015-11-19

Method and device for the synthesis of artemisinin

#35
20150307443
2015-10-29

FUNCTIONALIZED BENZAMIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST HBV INFECTION

#36
20150274637
2015-10-01

Biphenyl compounds for use in treating malaria and other parasitic disorders

#37
20150248052
2015-09-03

Photoresist composition, compound and process of producing photoresist pattern

#38
20150031896
2015-01-29

Compounds for organic electronic devices

#39
20140364630
2014-12-11

Method and device for the synthesis of artemisinin

#40
20140288317
2014-09-25

Aryloxyanilide imaging agents

#41
20140221468
2014-08-07

Compounds that Modulate Store Operated Calcium Channels

#42
20140117284
2014-05-01

2,2′-binaphthalene ester chiral dopants for cholesteric liquid crystal displays

#43
20140080832
2014-03-20

IRE-1α inhibitors

#44
20140054498
2014-02-27

2,2′-binaphthalene ester chiral dopants for cholesteric liquid crystal displays

#45
20130261174
2013-10-03

Pharmaceutical and food compositions for preventing or treating diabetes or obesity

#46
20120315580
2012-12-13

Salt, photoresist composition and method for producing photoresist pattern

#47
20120309670
2012-12-06

7-(alk-1′enyl)-2H-benzo[B][1,4]dioxepin-3(4H)-ones and their use in fragrance applications

#48
20120244073
2012-09-27

Aryloxyanilide imaging agents

#49
20120214785
2012-08-23

Compounds, pharmaceutical compositions and uses thereof

#50
20120122784
2012-05-17

Calcium sensing receptor modulating compounds and pharmaceutical use thereof

#51
20120088190
2012-04-12

Salt and photoresist composition comprising the same

#52
20120035149
2012-02-09

Prokineticin receptor antagonists and uses thereof

#53
20110065162
2011-03-17

IRE-1α inhibitors

#54
20100274051
2010-10-28

Inflammatory cytokine release inhibitor

#55
20100173905
2010-07-08

Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome

#56
20100076078
2010-03-25

Insecticidal compounds

#57
20100063282
2010-03-11

Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions, and Uses Thereof

#58
20090312392
2009-12-17

Amino ceramide-like compounds and therapeutic methods of use

#59
20090253908
2009-10-08

NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS

#60
20090247616
2009-10-01

USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF ANXIETY

#61
20090233952
2009-09-17

Substituted cycloalkene derivative

#62
20090233900
2009-09-17

2-aminobenzamide derivatives

#63
20090192122
2009-07-30

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#64
20090186893
2009-07-23

IRE-1α inhibitors

#65
20090182141
2009-07-16

PROCESS FOR THE PREPARATION OF SULFAMIDE DERIVATIVES

#66
20090069302
2009-03-12

CHEMICAL COMPOUNDS

#67
20090018116
2009-01-15

Therapeutic Compounds

#68
20080318956
2008-12-25

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#69
20080311113
2008-12-18

METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE

#70
20080306286
2008-12-11

Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof

#71
20080306142
2008-12-11

Isolation, purification and synthesis of procyanidin B2 and uses thereof

#72
20080300298
2008-12-04

Honokiol Derivates For the Treatment of Proliferative Disorders

#73
20080281108
2008-11-13

Chiral compounds

#74
20080272337
2008-11-06

Chiral compounds

#75
20080249071
2008-10-09

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#76
20080220285
2008-09-11

Materials for organic electroluminescent devices

#77
20080146533
2008-06-19

Amino ceramide-like compounds and therapeutic methods of use

#78
20080015191
2008-01-17

6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds

#79
20070293440
2007-12-20

Co-therapy for the treatment of epilepsy and related disorders

#80
20070259888
2007-11-08

Novel Compounds

#81
20070225329
2007-09-27

Aryl aniline βadrenergic receptor agonists

#82
20070225327
2007-09-27

Biaryl sulfonamides and methods for using same

#83
20070173542
2007-07-26

Peptide deformylase inhibitors

#84
20070142381
2007-06-21

Calcium receptor modulating agents

#85
20070117989
2007-05-24

7,7-disubstituted (5H,9H)-6,8-dioxabenzocycloheptene compounds useful in the synthesis of non-steroidal analogues of vitamin D

#86
20070042997
2007-02-22

Medicament for treatment of dermal pigmentation

#87
20070011823
2007-01-18

2,3-disubstituted primary para-phenylenediamines and process for oxidation dyeing of keratin fibers

#88
20060224023
2006-10-05

Process for the preparation of compounds having a CFO bridge

#89
20060178410
2006-08-10

Aryl aniline β2 adrenergic receptor agonists

#90
20060173058
2006-08-03

KCNQ channel modulating compounds and their pharmaceutical use

#91
20060111270
2006-05-25

Ketocampholenic acid derivatives and their use in fragrance applications

#92
20060058372
2006-03-16

N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them

#93
20060041008
2006-02-23

Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders

#94
20060004066
2006-01-05

Method for treating ADAMTS-5-associated disease

#95
20050288518
2005-12-29

1,2-substituted 2,3-dehydro-1H-5,9-dioxyacyclohepta[f]inden-7-ones and 7-substituted benzo[b]dioxepin-3-ones

#96
20050267094
2005-12-01

Amino ceramide-like compounds and therapeutic methods of use

#97
20050250951
2005-11-10

Chiral C2-symmetric biphenyls, their preparation and also metal complexes in which these ligands are present and their use as catalysts in chirogenic syntheses

#98
20050192316
2005-09-01

Aryl aniline βadrenergic receptor agonists

#99
20050143426
2005-06-30

Calcium receptor modulating agents

#100
20050130973
2005-06-16

Biaryl sulfonamides and methods for using same

#101
20050107339
2005-05-19

Diphenylethylene compounds and uses thereof

#102
20050049235
2005-03-03

Amino ceramide-like compounds and therapeutic methods of use

#103
20050020661
2005-01-27

Antidiabetic agents